Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4A1 pseudogene (ENSG00000271118) is a DNA sequence in the human genome that is highly homologous to the functional EIF4A1 gene but is incapable of producing a functional protein product[2][5]. Pseudogenes, such as this, arise by duplication or retrotransposition events and generally accumulate mutations that prevent their transcription or translation into functional proteins[2][5]. While most pseudogenes are considered nonfunctional, some may be transcribed into non-coding RNAs with potential regulatory roles, though this has not been conclusively demonstrated for this specific locus[5][8]. This pseudogene is not considered a therapeutic target, is not cataloged with interacting drugs, and does not play a direct role in disease mechanisms or drug discovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene.